Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Xinhua Silk Road
International Relation

China to donate 300,000 doses of Sinopharm vaccine to Sri Lanka

January 28, 2021


Abstract : China will donate 300,000 COVID-19 vaccine doses to Sri Lanka to jointly fight the COVID-19 pandemic.

A staff member checks the packaging quality of COVID-19 inactivated vaccine products at a packaging plant of the Beijing Biological Products Institute Co., Ltd., a subsidiary of Chinese pharmaceutical firm Sinopharm, in Beijing Dec. 25, 2020. (Xinhua/Zhang Yuwei)

The vaccine doses are expected to be handed over to the Sri Lankan side in mid-February after the due procedures in both ends are completed.

COLOMBO, Jan. 28 (Xinhua) -- China will donate 300,000 COVID-19 vaccine doses to Sri Lanka to jointly fight the COVID-19 pandemic.

A statement from the Chinese Embassy in Colombo said Wednesday that China made the decision after a recent request by the Sri Lankan government.

The vaccine doses are expected to be handed over to the Sri Lankan side in mid-February after the due procedures in both ends are completed, the statement said, noting that the vaccine is manufactured by the China National Pharmaceutical Group Co. Ltd (Sinopharm).

As an inactivated vaccine, it better ensures the safety of vaccines, and could be easily stored and transported at a regular fridge temperature of 2 to 8 degrees Celsius, the statement said.

Sri Lankan President Gotabaya Rajapaksa's senior advisor Lalith Weeratunga told journalists in capital Colombo earlier Wednesday that presently the National Medicines Regulatory Authority (NMRA) was conducting tests on the Sinopharm vaccine and once clearance is obtained from them, this vaccine could be used under an emergency basis.

Scan the QR code and push it to your mobile phone

Keyword: Sri Lanka COVID-19 vaccine

Reading:

Interview: IMF official stresses closer multilateral cooperation amid uneven global recovery

Interview: China's health cooperation offers "new paradigm" for int'l relations

Economic Watch: China's industrial profits grow steadily in 2020 as market demand improves

New Zealand dairy exports to China down in December: statistics

China steps up efforts to promote new infrastructure construction in 2021

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Identifying code Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial